LOADING
Comparing AbbVie Inc (ABBV) and Coca-Cola Company (KO) across the Health Care and Consumer Staples sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | KO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $362.8B | $321.2B |
| P/E Ratio | 86.2 | 24.6 |
| Forward P/E | 14.0 | 23.1 |
| PEG Ratio | 0.47 | 3.85 |
| EPS | $2.38 | $3.04 |
| Revenue Growth (YoY) | 10.0% | 2.4% |
| Profit Margin | 6.9% | 27.3% |
| Return on Equity | 62.3% | 43.3% |
| Dividend Yield | 3.26% | 2.73% |
| Beta | 0.36 | 0.36 |
| 52-Week High | $239.13 | $81.44 |
| 52-Week Low | $170.55 | $64.45 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Coca-Cola Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.